Clinical Biosafety Services, a subsidiary of Sabai Global
Shaun Tamprateep has extensive work experience in business communications and IT and operations system architecture. Shaun started working as a Business Communications Manager at Castle Institutional Review Board (Castle IRB) in January 2019 and is currently still in this role. Prior to that, they held the same position at Clinical Biosafety Services from September 2018 to present. Additionally, Shaun worked as an IT and Operations System Architect at Sabai Global and its subsidiaries CBS IBC, Castle IRB, and Shield Consulting from September 2017 to present.
Shaun Tamprateep obtained their Bachelor of Arts degree from Dhurakij Pundit University between the years 2005-2009. The specific field of study is not mentioned.
This person is not in any teams
Clinical Biosafety Services, a subsidiary of Sabai Global
Gene Therapy. Accelerated. Clinical Biosafety Services provides Institutional Biosafety Committee (IBC) Review and Biosafety Consulting Services. Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor. Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.